Artículo de revisión
Published on 16 de enero de 2025 | http://doi.org/10.5867/medwave.2025.01.3014
A systematic analysis of the literature on the post-COVID-19 condition in Latin America focusing on epidemiology, clinical characteristics, and risk of bias
| de Miranda | U | U | Y | Y | Y | Y | Y | Y | N | N | Y |
| Del Brutto, Mera | Y | Y | Y | Y | Y | Y | Y | Y | Y | N | Y |
| Del Brutto, Wu | Y | Y | Y | Y | Y | Y | Y | Y | Y | N | Y |
| Ferreira | Y | Y | Y | Y | Y | Y | Y | Y | N | N | Y |
| Milani | N | N | Y | Y | Y | Y | Y | Y | N | N | Y |
| Núñez | Y | Y | Y | Y | Y | Y | Y | Y | Y | Y | Y |
| Sívori | U | Y | Y | Y | Y | Y | Y | Y | N | N | Y |
| Wong-Chew | U | U | N | N | Y | Y | N | Y | N | N | Y |
Q1: Were the two groups similar and recruited from the same population?. Q2: Were the exposures measured similarly to assign people to both exposed and unexposed groups?. Q3: Was the exposure measured in a valid and reliable way?. Q4: Were confounding factors identified?. Q5: Were strategies to deal with confounding factors stated?. Q6: Were the groups/participants free of the outcome at the start of the study (or at the moment of exposure)?. Q7: Were the outcomes measured in a valid and reliable way?. Q8: Was the follow-up time reported and sufficient to be long enough for outcomes to occur?. Q9: Was the follow-up complete, and if not, were the reasons for the loss of follow-up described and explored?. Q10: Were strategies to address incomplete follow-up utilized?. Q11: Was appropriate statistical analysis used?. Y: Yes. N: No. U: Unclear. N/A: Not applicable.